IN2014DN06737A - - Google Patents
Info
- Publication number
- IN2014DN06737A IN2014DN06737A IN6737DEN2014A IN2014DN06737A IN 2014DN06737 A IN2014DN06737 A IN 2014DN06737A IN 6737DEN2014 A IN6737DEN2014 A IN 6737DEN2014A IN 2014DN06737 A IN2014DN06737 A IN 2014DN06737A
- Authority
- IN
- India
- Prior art keywords
- composition
- formulated
- present
- administration
- provides
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 4
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 206010014418 Electrolyte imbalance Diseases 0.000 abstract 1
- 206010051283 Fluid imbalance Diseases 0.000 abstract 1
- 206010017943 Gastrointestinal conditions Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 210000000813 small intestine Anatomy 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261596480P | 2012-02-08 | 2012-02-08 | |
| PCT/US2013/025294 WO2013119917A1 (en) | 2012-02-08 | 2013-02-08 | Materials and methods for treating diarrhea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06737A true IN2014DN06737A (en:Method) | 2015-05-22 |
Family
ID=48948047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6737DEN2014 IN2014DN06737A (en:Method) | 2012-02-08 | 2013-02-08 |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20140377374A1 (en:Method) |
| EP (1) | EP2812007B1 (en:Method) |
| JP (1) | JP6084238B2 (en:Method) |
| KR (2) | KR102262179B1 (en:Method) |
| CN (1) | CN104093410B (en:Method) |
| AP (1) | AP3941A (en:Method) |
| AU (1) | AU2013216871B2 (en:Method) |
| BR (1) | BR112014019350B1 (en:Method) |
| CA (1) | CA2863388C (en:Method) |
| EA (1) | EA034014B1 (en:Method) |
| ES (1) | ES2862392T3 (en:Method) |
| HK (1) | HK1204290A1 (en:Method) |
| IN (1) | IN2014DN06737A (en:Method) |
| MX (1) | MX368543B (en:Method) |
| WO (1) | WO2013119917A1 (en:Method) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103153298B (zh) | 2010-09-24 | 2015-11-25 | 佛罗里达大学研究基金会有限公司 | 用于改善胃肠功能的材料和方法 |
| BR112015021931A8 (pt) | 2013-03-11 | 2018-01-23 | Univ Florida | usos de composições farmacêuticas para prevenção e/ou tratamento de complicações do pulmão induzidas por radiação e da função pulmonar |
| CN107106527B (zh) * | 2014-11-24 | 2020-11-24 | 恩特林斯科健康解决方案股份公司 | 用于治疗疾病症状的氨基酸组合物 |
| CA3135553C (en) | 2016-10-04 | 2024-05-21 | University Of Florida Research Foundation, Incorporated | Amino acid compositions and uses thereof |
| WO2019070753A1 (en) * | 2017-10-02 | 2019-04-11 | University Of Florida Research Foundation, Incorporated | AMINO ACID COMPOSITIONS AND METHODS FOR TREATING DIARRHEA |
| JP2023531874A (ja) * | 2020-06-02 | 2023-07-26 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド | 下痢を治療するための製剤および方法 |
| CN116194136A (zh) | 2020-07-02 | 2023-05-30 | 佛罗里达大学研究基金会公司 | 用于促进水化的制剂及其使用方法 |
| CN118369093A (zh) * | 2021-05-28 | 2024-07-19 | 可口可乐公司 | 氨基酸水合配制品及使用方法 |
| CN115531363B (zh) * | 2021-06-30 | 2024-03-29 | 中国科学技术大学 | 预防、抑制或治疗轮状病毒感染的药物组合物及其用途 |
| US11878073B1 (en) | 2022-09-20 | 2024-01-23 | Entrinsic, LLC | Generation of hydration-targeted formulations and methods of use therein |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5290538A (en) * | 1988-12-22 | 1994-03-01 | Skrezek Christian | Nephro protective infusion solutions |
| JP3301646B2 (ja) * | 1993-03-19 | 2002-07-15 | シスメックス株式会社 | 幼若細胞測定用試薬 |
| ATE287703T1 (de) * | 1995-04-14 | 2005-02-15 | Nektar Therapeutics | Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit |
| JP4255656B2 (ja) * | 2001-09-17 | 2009-04-15 | 株式会社メニコン | 眼科用液剤及びコンタクトレンズ用液剤 |
| US20030143293A1 (en) * | 2002-01-31 | 2003-07-31 | Sergei Shushunov | Compositions and methods for treating diarrhea |
| JP2004123642A (ja) * | 2002-10-04 | 2004-04-22 | Shimizu Pharmaceutical Co Ltd | 電解質組成物 |
| DK175877B1 (da) * | 2002-11-11 | 2005-05-09 | Pharmalett As | Præparater til anvendelse som terapeutisk middel |
| US20050100637A1 (en) * | 2003-11-12 | 2005-05-12 | Robert Murray | Carbohydrate and electrolyte replacement composition |
| GB0503337D0 (en) * | 2005-02-17 | 2005-03-23 | Glaxosmithkline Biolog Sa | Compositions |
| JP4811576B2 (ja) * | 2005-03-31 | 2011-11-09 | 味の素株式会社 | 水分電解質補給飲料 |
| JP4512013B2 (ja) * | 2005-09-07 | 2010-07-28 | 和光堂株式会社 | 液体飲料組成物及びその製造方法 |
| DE102006018293A1 (de) * | 2006-04-20 | 2007-10-25 | Fresenius Kabi Deutschland Gmbh | Pädiatrische Aminosäurelösung zur parenteralen Ernäherung |
| CN103153298B (zh) * | 2010-09-24 | 2015-11-25 | 佛罗里达大学研究基金会有限公司 | 用于改善胃肠功能的材料和方法 |
| BR112015021931A8 (pt) * | 2013-03-11 | 2018-01-23 | Univ Florida | usos de composições farmacêuticas para prevenção e/ou tratamento de complicações do pulmão induzidas por radiação e da função pulmonar |
-
2013
- 2013-02-08 US US14/376,027 patent/US20140377374A1/en not_active Abandoned
- 2013-02-08 WO PCT/US2013/025294 patent/WO2013119917A1/en not_active Ceased
- 2013-02-08 EP EP13747028.2A patent/EP2812007B1/en active Active
- 2013-02-08 MX MX2014009557A patent/MX368543B/es active IP Right Grant
- 2013-02-08 BR BR112014019350-9A patent/BR112014019350B1/pt active IP Right Grant
- 2013-02-08 IN IN6737DEN2014 patent/IN2014DN06737A/en unknown
- 2013-02-08 KR KR1020207024016A patent/KR102262179B1/ko active Active
- 2013-02-08 CN CN201380008424.6A patent/CN104093410B/zh active Active
- 2013-02-08 EA EA201400827A patent/EA034014B1/ru not_active IP Right Cessation
- 2013-02-08 AP AP2014007916A patent/AP3941A/en active
- 2013-02-08 JP JP2014556712A patent/JP6084238B2/ja active Active
- 2013-02-08 AU AU2013216871A patent/AU2013216871B2/en active Active
- 2013-02-08 CA CA2863388A patent/CA2863388C/en active Active
- 2013-02-08 ES ES13747028T patent/ES2862392T3/es active Active
- 2013-02-08 HK HK15104949.7A patent/HK1204290A1/xx unknown
- 2013-02-08 KR KR1020147025066A patent/KR20140120941A/ko not_active Ceased
-
2015
- 2015-06-04 US US14/730,974 patent/US20150297636A1/en not_active Abandoned
-
2020
- 2020-07-31 US US16/945,040 patent/US20210299076A1/en not_active Abandoned
-
2024
- 2024-11-14 US US18/947,836 patent/US20250073260A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2812007B1 (en) | 2020-12-30 |
| US20210299076A1 (en) | 2021-09-30 |
| BR112014019350A8 (pt) | 2017-07-11 |
| CN104093410A (zh) | 2014-10-08 |
| BR112014019350B1 (pt) | 2020-09-24 |
| BR112014019350A2 (en:Method) | 2017-06-20 |
| EP2812007A4 (en) | 2015-09-09 |
| US20140377374A1 (en) | 2014-12-25 |
| EP2812007A1 (en) | 2014-12-17 |
| JP6084238B2 (ja) | 2017-02-22 |
| EA201400827A1 (ru) | 2014-12-30 |
| CA2863388A1 (en) | 2013-08-15 |
| MX368543B (es) | 2019-10-07 |
| KR102262179B1 (ko) | 2021-06-07 |
| AP2014007916A0 (en) | 2014-09-30 |
| US20150297636A1 (en) | 2015-10-22 |
| AU2013216871A1 (en) | 2014-09-11 |
| AU2013216871B2 (en) | 2017-08-17 |
| CA2863388C (en) | 2020-11-17 |
| KR20200105525A (ko) | 2020-09-07 |
| HK1204290A1 (en) | 2015-11-13 |
| ES2862392T3 (es) | 2021-10-07 |
| AP3941A (en) | 2016-12-16 |
| KR20140120941A (ko) | 2014-10-14 |
| US20250073260A1 (en) | 2025-03-06 |
| WO2013119917A1 (en) | 2013-08-15 |
| CN104093410B (zh) | 2018-04-27 |
| EA034014B1 (ru) | 2019-12-19 |
| MX2014009557A (es) | 2014-11-10 |
| JP2015506981A (ja) | 2015-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN06737A (en:Method) | ||
| MX2013004061A (es) | Analogos de ciclosporina. | |
| MY187540A (en) | Compounds active towards bromodomains | |
| PH12013501136A1 (en) | Lysophosphatidic acid receptor antagonists and uses thereof | |
| NZ709392A (en) | Synergistic bacterial compositions and methods of production and use thereof | |
| MX2019014045A (es) | Composiciones y metodos. | |
| MX2015015518A (es) | Metodos y composiciones para el tratamiento del cancer. | |
| GB201106750D0 (en) | Novel compounds | |
| IN2015DN01156A (en:Method) | ||
| WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
| MX367109B (es) | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. | |
| HK1218560A1 (zh) | 组成与方法 | |
| WO2014145958A3 (en) | Network-based microbial compositions and methods | |
| EA201491617A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| MX2011007930A (es) | Conjugados de insulina cristalina. | |
| MX2012007806A (es) | Composiciones farmaceuticas para administracion oral de peptidos de insulina. | |
| PH12013500441A1 (en) | Materials and methods for improving gastrointestinal function | |
| IN2012DN02735A (en:Method) | ||
| IN2012DN02730A (en:Method) | ||
| IN2012DN00754A (en:Method) | ||
| MX343135B (es) | Compuestos de tipo fumagilol y métodos de realización y uso de los mismos. | |
| GB201106743D0 (en) | Novel compounds | |
| MY162146A (en) | Pharmaceutical composition | |
| WO2015161243A3 (en) | Beta-lactamases with improved properties for therapy |